Niaid / childrens national medical center joint clinical research program (jcrp) immunologic and infectious diseases clinical research
Active Awarded Last action
- Contract number
- 75N91022F00021
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,001,104
Award facts
- Contract value 100% obligated
- $10,001,104.00 Current and potential, with all options
- Completion date 83% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $5,689,793 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $417,547 | |
| Original award | $3,893,764 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Leidos Biomedical Research Inc. on September 2, 2022, with a ceiling value of $10.001 million for the NIAID/Children's National Medical Center Joint Clinical Research Program covering immunologic and infectious diseases clinical research.
This delivery order is issued under Leidos Biomedical Research's master NIAID FFRDC contract. Place of performance is Frederick, MD. The order is cost-plus-fixed-fee and runs through September 1, 2027.
Service Contract Inventory reporting shows this order invoiced $100 thousand in FY2022, $194 thousand in FY2023 (0.9 FTEs, 1,860 contractor hours), $626 thousand in FY2024 (11.7 FTEs, 24,416 contractor hours), and $776 thousand in FY2025 (4.1 FTEs, 8,488 contractor hours). Government-paid blended hourly rates were $104.03/hr in FY2023, $25.65/hr in FY2024, and $91.42/hr in FY2025. In FY2025, 93 percent of contractor hours were subcontracted to one named subcontractor.
Quick answers
Who was awarded contract 75N91022F00021?
75N91022F00021 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 2, 2022.
How much is contract 75N91022F00021 worth?
The government has obligated $10,001,104 on 75N91022F00021.
Which agency awarded contract 75N91022F00021?
National Cancer Institute (National Institutes of Health) awarded 75N91022F00021, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91022F00021 an order under another contract?
Yes. 75N91022F00021 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91022F00021 competed?
The extent of competition for 75N91022F00021 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award